303 related articles for article (PubMed ID: 15986357)
1. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
[TBL] [Abstract][Full Text] [Related]
2. Dichotomous effects of complete versus partial class II major histocompatibility complex deficiency on circulating autoantibody levels in autoimmune-prone mice.
Stohl W; Xu D; Metzger TE; Kim KS; Morel L; Kotzin BL
Arthritis Rheum; 2004 Jul; 50(7):2227-39. PubMed ID: 15248222
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
4. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
[TBL] [Abstract][Full Text] [Related]
5. CD19 hyperexpression augments Sle1-induced humoral autoimmunity but not clinical nephritis.
Shi X; Xie C; Chang S; Zhou XJ; Tedder T; Mohan C
Arthritis Rheum; 2007 Sep; 56(9):3057-69. PubMed ID: 17763445
[TBL] [Abstract][Full Text] [Related]
6. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
7. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
8. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
9. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.
Jørgensen TN; Roper E; Thurman JM; Marrack P; Kotzin BL
Genes Immun; 2007 Dec; 8(8):653-62. PubMed ID: 17882225
[TBL] [Abstract][Full Text] [Related]
10. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
[TBL] [Abstract][Full Text] [Related]
11. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF.
Jacob CO; Pricop L; Putterman C; Koss MN; Liu Y; Kollaros M; Bixler SA; Ambrose CM; Scott ML; Stohl W
J Immunol; 2006 Aug; 177(4):2671-80. PubMed ID: 16888029
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
14. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
[TBL] [Abstract][Full Text] [Related]
15. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
[TBL] [Abstract][Full Text] [Related]
16. Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity.
Stohl W; Jacob N; Guo S; Morel L
Arthritis Rheum; 2010 Aug; 62(8):2432-42. PubMed ID: 20506216
[TBL] [Abstract][Full Text] [Related]
17. Induction of systemic lupus erythematosus syndrome in BALB/c mice by immunization with active chromatin.
Li H; Zhang YY; Sun YN; Huang XY; Jia YF; Li D
Acta Pharmacol Sin; 2004 Jun; 25(6):807-11. PubMed ID: 15169636
[TBL] [Abstract][Full Text] [Related]
18. The lupus susceptibility locus Sle1 facilitates the peripheral development and selection of anti-DNA B cells through impaired receptor editing.
Chang SH; Kim TJ; Kim YJ; Liu Y; Min SY; Park MJ; Park HS; Lee SK; Nam KH; Kim HY; Mohan C; Kim HR
J Immunol; 2014 Jun; 192(12):5579-85. PubMed ID: 24835399
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
20. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis.
Liu K; Li QZ; Yu Y; Liang C; Subramanian S; Zeng Z; Wang HW; Xie C; Zhou XJ; Mohan C; Wakeland EK
Genes Immun; 2007 Dec; 8(8):634-45. PubMed ID: 17728789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
